Emily M. Leproust, Chief Executive Officer at Twist Bioscience Corp (TWST), sold 41,570 shares at $150.56 ($6.3M) on 2026-08-25, disclosed to the SEC on 2026-08-27.
Scheduled sale ($6.3M) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $150.56 | 12,648 | $1.9M | 30.1% |
| 2 | $151.35 | 12,236 | $1.9M | 29.3% |
| 3 | $152.75 | 6,412 | $979K | 15.5% |
| 4 | $153.93 | 9,181 | $1.4M | 22.4% |
| 5 | $154.45 | 1,093 | $169K | 2.7% |
| Total | $151.98 avg | 41,570 |
| $6.3M |
| 100% |
| Filing → |
| TWST | SELL | 2026-09-23 | $279K | — | Filing → |
| TWST | SELL | 2026-09-21 | $56.3M | — | Filing → |
| TWST | SELL | 2026-09-10 | $282K | — | Filing → |